Paper Details

  1. Home
  2. Paper Details

Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.

Author: TanabeT

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Disopyramide and mexiletine, both used to suppress ventricular arrhythmias, were equally effective when used alone or in combination. The combination therapy was associated with fewer side effects than single-drug therapy.
Paper Details　
Original Abstract of the Article :
Ventricular arrhythmia suppression trials were performed to compare the efficacies and side effects of disopyramide and mexiletine used alone and in combination, and to compare the efficacies and side effects of mexiletine and propranolol used alone and in combination, in patients with chronic ventr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/BF00120831

データ提供：米国国立医学図書館（NLM）

Combination Antiarrhythmic Treatment: A Complex Journey Through the Desert

Ventricular arrhythmias, irregular heartbeats that originate in the lower chambers of the heart, can be life-threatening. This study investigated the effectiveness and safety of combining different antiarrhythmic drugs to suppress these arrhythmias. The researchers examined the effects of various combinations of disopyramide, mexiletine, and propranolol, common antiarrhythmic medications, on the frequency and severity of ventricular premature contractions (VPCs).

A Multifaceted Approach: Navigating the Desert with Multiple Strategies

The study found that combining disopyramide and mexiletine was effective in suppressing VPCs, and the combination therapy appeared to be better tolerated than either drug alone. This suggests that combining different antiarrhythmic drugs may be a valuable approach to managing ventricular arrhythmias. It's like utilizing multiple camels to carry a heavy load across the desert, each camel contributing its unique strength and resilience to the journey.

A Balancing Act: The Desert of Arrhythmias

The study highlights the importance of careful monitoring and management when using antiarrhythmic medications. It's like navigating a desert with shifting sands, requiring constant vigilance and adjustments to maintain a safe and effective course. It's a complex journey, but with careful planning and a multifaceted approach, we can find our way through the desert of arrhythmias.

Dr.Camel's Conclusion

This study emphasizes the need for tailored and individualized approaches to managing ventricular arrhythmias. Combining different antiarrhythmic medications may offer a valuable strategy, but it's crucial to weigh the potential benefits against the risks and carefully monitor patients to ensure the best possible outcomes. It's a journey through the desert of arrhythmias, requiring careful navigation and a steadfast commitment to patient care.

Date :
  1. Date Completed 1991-12-04
  2. Date Revised 2019-09-12
Further Info :

Pubmed ID

1931759

DOI: Digital Object Identifier

10.1007/BF00120831

Related Literature

Article Analysis
・Side Effects of disopyramide
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.